| Literature DB >> 34833898 |
David Pertuit1, Anne-Claire Mitaine-Offer1, Tomofumi Miyamoto2, Chiaki Tanaka2, Christine Belloir3, Loïc Briand3, Marie-Aleth Lacaille-Dubois1.
Abstract
Four oleanane-type glycosides were isolated from a horticultural cultivar "Green Elf" of the endemic Pittosporum tenuifolium (Pittosporaceae) from New Zealand: three acylated barringtogenol C glycosides from the leaves, with two previously undescribed 3-O-β-d-glucopyranosyl-(1→2)-[α-l-arabinopyranosyl-(1→3)]-β-d-glucuronopyranosyl-21-O-angeloyl-28-O-acetylbarringtogenol C, 3-O-β-d-galactopyranosyl-(1→2)-[α-l-arabinopyranosyl-(1→3)]-β-d-glucuronopyranosyl-21-O-angeloyl-28-O-acetylbarringtogenol C, and the known 3-O-β-d-glucopyranosyl-(1→2)-[α-l-arabinopyranosyl-(1→3)]-β-d-glucuronopyranosyl-21-O-angeloyl-28-O-acetylbarringtogenol C (Eryngioside L). From the roots, the known 3-O-β-d-glucopyranosyl-(1→2)-β-d-galactopyranosyl-(1→2)-β-d-glucuronopyranosyloleanolic acid (Sandrosaponin X) was identified. Their structures were elucidated by spectroscopic methods including 1D- and 2D-NMR experiments and mass spectrometry (ESI-MS). According to their structural similarities with gymnemic acids, the inhibitory activities on the sweet taste TAS1R2/TAS1R3 receptor of an aqueous ethanolic extract of the leaves and roots, a crude saponin mixture, 3-O-β-d-glucopyranosyl-(1→2)-[α-l-arabinopyranosyl-(1→3)]-β-d-glucuronopyranosyl-21-O-angeloyl-28-O-acetylbarringtogenol C, and Eryngioside L were evaluated.Entities:
Keywords: Pittosporaceae; Pittosporum tenuifolium; TAS1R2/TASR3; barringtogenol C; sweet taste; taste inhibitor
Mesh:
Substances:
Year: 2021 PMID: 34833898 PMCID: PMC8625740 DOI: 10.3390/molecules26226805
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Structures of compounds 1 and 2.
1H (600 MHz) and 13C (150 MHz) NMR data of the aglycone moieties of compounds 1 and 2 in pyridine-d5 (δ in ppm, J in parentheses in Hz) a.
| Position | 1 | 2 | ||
|---|---|---|---|---|
|
|
|
|
| |
| 1 | 38.6 | 0.84 | 38.6 | 0.85 |
| 2 | 26.1 | 1.94 m | 26.1 | 1.92 |
| 3 | 90.3 | 3.30 dd (11.4, 3.8) | 89.9 | 3.28 |
| 4 | 39.4 | - | 39.4 | - |
| 5 | 55.5 | 0.74 d (11.4) | 55.6 | 0.74 br d (11.4) |
| 6 | 18.2 | 1.30 | 18.2 | 1.30 |
| 7 | 32.8 | 1.30 | 32.9 | 1.30 |
| 8 | 39.7 | - | 39.7 | - |
| 9 | 46.7 | 1.68 m | 46.7 | 1.68 |
| 10 | 36.5 | - | 36.5 | - |
| 11 | 23.6 | 1.86 | 23.6 | 1.84 |
| 12 | 123.9 | 5.50 | 124.0 | 5.49 |
| 13 | 142.2 | - | 142.4 | - |
| 14 | 41.5 | - | 41.5 | - |
| 15 | 34.1 | 1.71 m | 34.2 | 1.71 |
| 16 | 67.4 | 4.74 br s | 67.4 | 4.74 br s |
| 17 | 47.0 | - | 47.0 | - |
| 18 | 40.3 | 2.85 dd (13.2, 3.1) | 40.3 | 2.86 br d (13.7) |
| 19 | 46.8 | 1.44 m | 46.8 | 1.45 m |
| 20 | 35.8 | - | 35.8 | - |
| 21 | 81.0 | 6.40 d (9.9) | 81.0 | 6.41 d (10.0) |
| 22 | 71.0 | 4.48 | 71.0 | 4.48 |
| 23 | 27.6 | 1.19 s | 27.7 | 1.27 s |
| 24 | 16.4 | 1.09 s | 16.5 | 1.14 s |
| 25 | 15.4 | 0.82 s | 15.4 | 0.81 s |
| 26 | 16.8 | 0.98 s | 16.8 | 0.97 s |
| 27 | 27.1 | 1.81 s | 27.1 | 1.81 s |
| 28 | 66.2 | 4.26 | 66.2 | 4.26 |
| 29 | 29.5 | 1.12 s | 29.5 | 1.11 s |
| 30 | 19.9 | 1.33 s | 19.9 | 1.33 s |
| Ang at C-21 | Ang at C-21 | |||
| 1′ | 168.8 | - | 168.7 | - |
| 2′ | 129.0 | - | 129.1 | - |
| 3′ | 136.2 | 5.98 q (7.3) | 136.1 | 5.97 q (6.8) |
| 4′ | 15.7 | 2.07 d (6.7) | 15.7 | 2.06 d (6.8) |
| 5′ | 20.8 | 2.01 s | 20.8 | 2.01 s |
| Ac at C-28 | Ac at C-28 | |||
| 1″ | 171.0 | - | 170.9 | - |
| 2″ | 20.5 | 2.06 s | 20.5 | 2.04 s |
a Overlapped signals are reported without designated multiplicity. δ in ppm; J in parentheses in Hz.
Figure 2Key HMBC correlations of the aglycone moiety of compound 1.
Figure 3Key ROESY correlations of the aglycone moiety of compound 1.
1H (600 MHz) and 13C (150 MHz) NMR data of the sugar moieties of compounds 1 and 2 in pyridine-d5 (δ in ppm, J in parentheses in Hz) a.
| Position | 1 | 2 | ||
|---|---|---|---|---|
|
|
|
|
| |
| 3- | 3- | |||
| 1 | 104.6 | 4.85 d (7.3) | 104.7 | 4.85 d (7.6) |
| 2 | 77.9 | 4.52 | 78.8 | 4.48 |
| 3 | 84.8 | 4.40 t (8.8) | 84.9 | 4.36 |
| 4 | 71.9 | 4.24 | 71.3 | 4.22 |
| 5 | 76.9 | 4.33 m | 76.5 | 4.32 |
| 6 | Nd | Nd | ||
| Glc | Gal | |||
| 1 | 103.0 | 5.65 d (7.0) | 103.8 | 5.49 d (7.6) |
| 2 | 75.8 | 4.05 t (8.4) | 73.2 | 4.46 |
| 3 | 77.9 | 4.27 | 74.7 | 4.13 |
| 4 | 72.0 | 3.99 dd (9.3, 8.7) | 69.6 | 4.49 |
| 5 | 78.2 | 3.92 m | 76.5 | 3.92 m |
| 6 | 62.9 | 4.23 | 61.7 | 4.36 |
| Ara | Ara | |||
| 1 | 104.2 | 5.38 d (7.6) | 104.2 | 5.33 d (7.6) |
| 2 | 72.4 | 4.47 | 72.4 | 4.47 |
| 3 | 74.0 | 4.16 dd (9.3, 2.6) | 74.1 | 4.13 |
| 4 | 69.1 | 4.26 | 69.2 | 4.26 |
| 5 | 66.9 | 3.78 d (12.0) | 67.0 | 3.74 d (12.3) |
a Overlapped signals are reported without designated multiplicity. Nd: not determined.
Figure 4Sucralose responses of hTAS1R2/hTAS1R3 treated by PTGE L, PTGE R, CSM, 1, EL, and GS.